The former company Erin Resources, was engaged in gold exploration. The Company held various interests in seven prospective gold assets located in the Republic of Senegal, being the Lingokoto, Bouroubourou, Wassadou North and South, Woye, Garaboureya South and Balakonko gold projects. In May 2015 the Company announced that is had entered into a binding heads of agreement under which it has the option to acquire 100% of the issued capital of MGC Global Limited (MGC Global). This reverse takeover transaction was approved and completed in December 2015, after which the company began trading under the name MGC Pharmaceuticals (ASX: MXC)
